Bontril (Phendimetrazine) for Obesity | MyObesityTeam

Connect with others who understand.

sign up Log in
About MyObesityTeam
Powered By

Bontril is a prescription drug approved by the Food and Drug Administration (FDA) for short-term weight management in conjunction with a reduced-calorie diet and exercise. Bontril may be prescribed for adults with a body mass index (BMI) of 30 or greater. Adults with a BMI of 27 or greater may be considered candidates for Bontril if they have at least one weight-related medical condition. Bontril is also referred to by its drug name, Phendimetrazine.

Bontril is a stimulant and an appetite suppressant. It is believed that Bontril works by reducing the perception of hunger.

How do I take it?
Prescribing information states that Bontril should be taken two or three times a day.

Bontril comes in tablet form.

Side effects
The FDA-approved label for Bontril lists common side effects including headache, dizziness, restlessness, insomnia, hyperactivity, dry mouth, upset stomach, constipation, diarrhea, and changes in sexual interest or ability.

Rare but serious side effects listed for Bontril include pulmonary hypertension and valvular heart disease.

For more details about this treatment, visit:
Bontril – RxList

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in